Therapeutic Approach

Archive: January, 2020

Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement

  Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement Transaction to Create a Nasdaq-listed Biotechnology Company Focused on Advancing Qualigen’s Cancer and Infectious Disease Therapeutic Development Programs LOS ANGELES (January 21, 2020) – Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of therapeutic products that modulate the gut microbiome to […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD